IE31963L - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
IE31963L
IE31963L IE671421A IE142167A IE31963L IE 31963 L IE31963 L IE 31963L IE 671421 A IE671421 A IE 671421A IE 142167 A IE142167 A IE 142167A IE 31963 L IE31963 L IE 31963L
Authority
IE
Ireland
Prior art keywords
groups
nov
methyl
angina pectoris
pharmaceutical compositions
Prior art date
Application number
IE671421A
Other versions
IE31963B1 (en
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Priority to IE288/72A priority Critical patent/IE31964B1/en
Publication of IE31963L publication Critical patent/IE31963L/en
Publication of IE31963B1 publication Critical patent/IE31963B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

1,201,460. Medicines for treating angina pectoris. BOEHRINGER INGELHEIM G.m.b.H. 24 Nov., 1967 [25 Nov., 1966; 5 Sept. 1967], No. 3899/70. Divided out of 1,194,548. Addition to 1,194,548. Heading A5B. Pharmaceutical compositions for the treatment of angina pectoris comprise, as active ingredients, at least one #-andrenolytic agent and at least one coronary dilator selected from: 3-(#-diethyl-aminoethyl)-4-methyl-7-carbethoxymethyl-2-oxo-2H-chromen; 3,3'-(N,N-dimethyl -ethylenediamino)- bis -(propyl-3,4,5-trimethoxy benzoate); N-3'-phenylpropyl-(2')-1,1-diphenyl- (3)-amine; α-isopropyl-α-[N-(methyl-N-homovenatryl)- γ -aminopropyl]-3,4-dimethoxyphenyl -acetonitrile and L-#-(#-hydroxy-α-methylphenylethylamino)- 3 -methoxypropiophenone. Preferred #-advenolytics are those of the general formula: ArO-CH 2 -CH.OH-CH 2 - NHR in which Ar is a phenyl, naphthyl, tetrahydronaphthyl or indenyl group optionally substituted with one or more C 1-6 alkyl groups, -CF 3 , -NH 2 ,-CN or halogen; lower alkoxy, alkenyloxy, alkynyloxy, acyloxy, acyl, alkoxyalkyl, alkenyl, alkynyl, alkylthio or mono- or di-alkylamino groups with up to 6 carbon atoms in each hydrocarbon moiety, or -NO 2 , -OH or -O-CH 2 -O- groups, and R is a C 1-6 alkyl or C 7-10 aralkyl radical. The active compounds may be used in the form of their acid addition salts and the compositions may be in conventional forms for oral, rectal and parenteral administration. [GB1201460A]
IE1421/67A 1966-11-25 1967-11-27 Improvements in compositions comprising beta-adrenolytics IE31963B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IE288/72A IE31964B1 (en) 1966-11-25 1967-11-27 Improvements in compositions comprising beta-adrenolytics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEB0090017 1966-11-25

Publications (2)

Publication Number Publication Date
IE31963L true IE31963L (en) 1968-05-25
IE31963B1 IE31963B1 (en) 1973-03-07

Family

ID=6985072

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1421/67A IE31963B1 (en) 1966-11-25 1967-11-27 Improvements in compositions comprising beta-adrenolytics

Country Status (5)

Country Link
BE (1) BE707050A (en)
DE (1) DE1617336C2 (en)
FR (1) FR7514M (en)
GB (2) GB1194548A (en)
IE (1) IE31963B1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3937834A (en) 1970-10-02 1976-02-10 Ciba-Geigy Corporation Pharmaceutical preparations
US4060601A (en) 1976-06-15 1977-11-29 Merck & Co., Inc. Certain lower-alkyl amino-2'-hydroxy-propoxy pyridines
DE3833393A1 (en) * 1988-10-01 1990-04-05 Thomae Gmbh Dr K USE OF PTERIDINES TO PREVENT PRIMARY AND SECONDARY RESISTANCE IN CHEMOTHERAPY AND MEDICINES CONTAINING THESE COMPOUNDS

Also Published As

Publication number Publication date
BE707050A (en) 1968-05-24
FR7514M (en) 1969-12-15
DE1617336C2 (en) 1982-07-01
DE1617336A1 (en) 1970-12-10
IE31963B1 (en) 1973-03-07
GB1201460A (en) 1970-08-05
GB1194548A (en) 1970-06-10

Similar Documents

Publication Publication Date Title
ATE37179T1 (en) DIHYDROPYRIDAZINONES.
FI820281L (en) FREQUENCY COMPOSITION FOR 2-PENEMICAL COMPOSITION WITH FRAMEWORK FOR 2-PENEMICAL COMPOSITION OF THE EUROPEAN PHARMACEUTICAL FORM
EP0092391A3 (en) Novel piperidine derivatives and pharmaceutical compositions containing same
SE8204237L (en) CARBOSTYRIC ASSOCIATIONS, COMPOSITIONS CONTAINING THESE AND THE PROCEDURES FOR PREPARING THEREOF
GB1247113A (en) Oxindole carboxamides
GB1351501A (en) Adenosine derivatives and the production thereof
SE7906472L (en) NEW 3- (AMINOETHYL) -PHENOL DERIVATIVES AND SALTS THEREOF, SET FOR PREPARATION AND USE OF THEM AS MEDICINAL AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
KR890013028A (en) Cephalosporin derivatives and their preparation
GB1201460A (en) IMPROVEMENTS IN COMPOSITIONS COMPRISING beta-ADRENOLYTICS
GB1180794A (en) Novel Arylhydrazino-Imidazolines and Preparation Thereof
DK601683D0 (en) DIALKYLAMINOALCOXYBENZYL ALCOHOL DERIVATIVES
GB1169945A (en) Pharmaceutical Compositions containing Diphenylalkyl-amine Derivatives
GB1185045A (en) Amine Derivatives
GB1530569A (en) Semi-synthetic oleandomycin derivatives-c8 modifications
IE832680L (en) Nitrosourea derivatives.
ES435361A1 (en) 2-Methyl-1-(substituted)phenyl-2-propyl esters of 2-aminopropanoic acid
FR1602627A (en) 3 omega-subst alkyl indoles
FI853866A0 (en) 2-PYRIDIN-THIOL DERIVATIVES, FOERFARANDE FOER FRAMSTAELLNING AV DESSA SAMT PHARMACEUTICAL FOERENINGAR INNEHAOLLANDE DESSA.
SE8303719L (en) EBURNAN OXIMIZE DERIVATIVES, PROCEDURE FOR PREPARING THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE ASSOCIATIONS
HK67287A (en) Ergoline derivatives
GB1354451A (en) Halogen-substituted phenyl-alkylamines and their derivatives
GB1043519A (en) New basic alcohols
ES486580A1 (en) A PROCEDURE FOR PREPARING COMPOUNDS WITH BRONCHODILATING PROPERTIES
GB1272340A (en) Derivatives of neriifolin
ES8201539A1 (en) Orthoarylideneaminophenethylamines and pharmaceutical compositions